Jan 13, 2017 12:30 PM IST IST | Source: Moneycontrol.com

Lupin up 2%, launches generic MS Contin ER tablets in US

The company has launches Morphine Sulfate ER tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval from United State Food and Drug Administration (USFDA).

Moneycontrol Bureau

Share price of Lupin rose as much as 2 percent intraday Friday after launching tablets in the US market.

The company has launches Morphine Sulfate ER tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval from United State Food and Drug Administration (USFDA).

Morphine Sulfate ER tablets are the AB rated generic equivalent of Purdue Pharma’s MS Contin ER tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg.

MS Contin ER tablets had US sales of USD 282.9 million as per IMS MAT September 2016 data.

Posted by Rakesh Patil
Sections
Follow us on
Available On